Mersana Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

3 years ago

CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ: MRSN) a clinical-stage biopharmaceutical company focused on discovering…

Sientra Announces Acquisition of Novel Fat Grafting Technology from AuraGen Aesthetics, LLC

3 years ago

Broadens Sientra’s opportunity within the estimated $13 billion U.S. plastic surgery market1 with the addition of a highly differentiated, FDA-cleared…

Halberd Corporation Now an Official US Government Contractor

3 years ago

Halberd to bid on Additional Federal Contracts with the Federal GovernmentJackson Center, Pennsylvania--(Newsfile Corp. - January 5, 2022) - Halberd…

Awakn Life Sciences Expands World’s First Ketamine Study Beyond Gambling Disorder to Include Additional Behavioral Addictions

3 years ago

Groundbreaking Psychedelic Study Will Investigate Binge Eating Disorder, Compulsive Sexual Behavior, and Internet Gaming DisorderToronto, Ontario--(Newsfile Corp. - January 5,…

Stephanie Reisinger to Lead Flatiron Health’s Real-World Evidence Business

3 years ago

Former Veradigm Executive Brings Extensive Experience in EHR-Derived Real-World Data NEW YORK--(BUSINESS WIRE)--Flatiron HealthⓇ today announced the appointment of Stephanie…

Hologic Adds Aptima SARS-CoV-2 Assay to its Global Access Initiative in Resource-Limited Countries

3 years ago

MARLBOROUGH, Mass.--(BUSINESS WIRE)--#Africa--Hologic, Inc. (NASDAQ: HOLX) announces the addition of the Aptima® SARS-CoV-2 assay to its Global Access Initiative (GAI),…

Leiden University Medical Center and Intravacc to Start Clinical Trial with New Intranasal Corona Vaccine

3 years ago

Nasal spray vaccine based on soluble nano-spheres with synthetic corona proteinsNo use of mRNA or vector technologyBetter and direct immunization…

Relief Therapeutics to Participate in Virtual Investor Conferences in January

3 years ago

GENEVA, SWITZERLAND / ACCESSWIRE / January 5, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a…

NervGen Pharma Applauds President Biden Signing Defense Bill

3 years ago

Department of Defense now able to Move Forward on Brain Plasticity ResearchCincinnati, Ohio--(Newsfile Corp. - January 4, 2022) - NervGen…

Senseonics Announces Business Updates

3 years ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,…